Regencell Bioscience (RGC) has had the highest return since January 1, 2025 by a small-cap US stock, returning 4,073.2%.
| ASSET | % RETURN |
|---|---|
Regencell Bioscience (RGC) | 4,073.23% |
Diginex Limited Ordinary Shares (DGNX) | 1,250% |
Regulus Therapeutics (RGLS) | 390.63% |
ThredUp (TDUP) | 342.36% |
Twin Hospitality (TWNP) | 286.88% |
Nutex Health (NUTX) | 276.8% |
Marblegate Acquisition (GATE) | 229.22% |
QuantaSing Group Limited American Depositary Shares (QSG) | 208.14% |
CuriosityStream (CURIW) | 191.25% |
Upexi (UPXI) | 183.89% |
Avino Silver & Gold Mines (ASM) | 167.34% |
TMC the metals (TMC) | 166.67% |
Chimerix (CMRX) | 143.3% |
Park Ha Biological Technology (PHH) | 139.23% |
Digital Turbine (APPS) | 137.36% |
Trivago (TRVG) | 121.46% |
Patriot National Bancorp (PNBK) | 120% |
Porch (PRCH) | 118.04% |
Vasta Platform (VSTA) | 115.25% |
Heritage Insurance Hldgs (HRTG) | 112.77% |
Aeva Technologies, Inc Common Stock (AEVA) | 109.67% |
Fubotv (FUBO) | 107.69% |
GRAIL, LLC (GRAL) | 102.58% |
Jiayin (JFIN) | 99.36% |
Groupon (GRPN) | 98.61% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
